A randomized phase 2 trial of socrodeucitinib in moderate‐to‐severe plaque psoriasis
In moderate‐to‐severe plaque psoriasis, socrodeucitinib (6 mg/12 mg) significantly outperformed placebo at week 12: PASI 75 response rates 28.6%/72.1% vs. 7.5%. Meanwhile, socrodeucitinib illustrated a favourable safety and tolerability profile, warranting further study.
Ling Han +24 more
wiley +1 more source
Gliomas phenocopy an inborn error of metabolism to drive neuronal activity and tumor growth. [PDF]
Abdullah KG +67 more
europepmc +1 more source
Adaptation to extreme environments: A review of Antarctic fish physiology
Abstract Having evolved in the chronically cold and thermally stable waters of the Southern Ocean (SO) for millions of years, Antarctic fish possess a suite of physiological specializations that enable them to survive at temperatures near the freezing point of seawater. Adaptations include the evolution of antifreeze proteins, modifications of membrane
Seungyeon Lee +8 more
wiley +1 more source
Dietary Patterns and Nutritional Interventions for Cognitive Impairment in Parkinson's Disease: A Critical Narrative Review. [PDF]
Aldakheel A, Qadi N.
europepmc +1 more source
Rehabilitation Nutrition for Tendon and Ligament Injuries: From Collagen Remodeling to Return-to-Activity and Sport. [PDF]
Lee EJ, Kim J.
europepmc +1 more source
Recurrent Severe Viral-Induced Rhabdomyolysis Associated With Underlying Genetic Variants in a Young Adult: A Case Report. [PDF]
Stone AM +13 more
europepmc +1 more source
Nutritional Strategies for Recovery-Adaptation Coupling After Exercise: From Muscle Damage to Performance Remodeling. [PDF]
Mănescu DC +12 more
europepmc +1 more source
Creatine Supplementation in Crohn's Disease: Possible Therapeutic Trends in Symptoms and Muscle Tissue Integrity. [PDF]
Papadimitriou K +4 more
europepmc +1 more source

